February 7, 2008 (Chicago, IL) - Doctors and regulators concerned about the spike in off-label patent foramen ovale (PFO) closure procedures now have some numbers to fall back on. A research letter ...

Rochester, MN - A new case series of patients with a previous stroke suggests that transcatheter device closure of patent foramen ovale (PFO) and atrial septal defect (ASD) is safe and eliminated ...

Long-term survival after transcatheter closure of secundum atrial septal defects (ASD) is similar to that achieved after surgical closure, but the former method is far more likely to require ...

Please provide your email address to receive an email when new articles are posted on . W.L. Gore and Associates announced its occluder device was approved by the FDA for percutaneous closure of ...

A novel study by Canadian physicians reported that the BioSTAR biodegradable implant achieved comparable closure rates to the Amplatzer Septal Occluder in children with atrial septal defect. A novel ...

Overall, there was a 15.8% incidence of migraines in the first 3 months following the procedure among people randomized to clopidogrel (Plavix) plus aspirin or aspirin alone. After this initial period ...

Thrissur General Hospital’s Cardiology department has marked a major milestone in cardiac care by successfully performing a rare heart procedure known as an ‘Atrial Septal Defect (ASD) Device Closure’ ...

Tawam Hospital, the UAE and Gulf region's premier healthcare provider, organised an interventional cardiology workshop, in the period from 12-16 November, 2006. Dr Michael Slack, an internationally ...

Atrial septal defect (ASD) can cause chronic right chamber volume overload, leading to arrhythmias and impaired left ventricular function. ASD closure has been shown to be less effective after ...

ORLANDO, FL—Three months of clopidogrel on top of aspirin appears to reduce the number and severity of migraines following atrial septal defect (ASD) closure, a new study suggests. The findings, while ...